ID28984A - Fosfoglikolipid dan metoda penggunannya - Google Patents

Fosfoglikolipid dan metoda penggunannya

Info

Publication number
ID28984A
ID28984A IDW20010665A ID20010665A ID28984A ID 28984 A ID28984 A ID 28984A ID W20010665 A IDW20010665 A ID W20010665A ID 20010665 A ID20010665 A ID 20010665A ID 28984 A ID28984 A ID 28984A
Authority
ID
Indonesia
Prior art keywords
compound
deoxy
ischemia
damage due
reperfusion injury
Prior art date
Application number
IDW20010665A
Other languages
English (en)
Indonesian (id)
Inventor
Gary T Elliot
Patricia A Weber
Gregory C Sowell
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of ID28984A publication Critical patent/ID28984A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IDW20010665A 1998-08-21 1999-08-18 Fosfoglikolipid dan metoda penggunannya ID28984A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/138,305 US6013640A (en) 1998-08-21 1998-08-21 Phosphoglycolipid and methods for its use

Publications (1)

Publication Number Publication Date
ID28984A true ID28984A (id) 2001-07-19

Family

ID=22481436

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010665A ID28984A (id) 1998-08-21 1999-08-18 Fosfoglikolipid dan metoda penggunannya

Country Status (19)

Country Link
US (2) US6013640A (de)
EP (1) EP1105401B1 (de)
JP (1) JP2002523420A (de)
KR (1) KR20010072806A (de)
CN (1) CN1324364A (de)
AT (1) ATE263776T1 (de)
AU (1) AU754186B2 (de)
BR (1) BR9913175A (de)
CA (1) CA2340649A1 (de)
CZ (1) CZ2001637A3 (de)
DE (1) DE69916289D1 (de)
HU (1) HUP0103473A3 (de)
ID (1) ID28984A (de)
IL (1) IL141496A0 (de)
NO (1) NO20010854L (de)
NZ (1) NZ510260A (de)
PL (1) PL349422A1 (de)
TR (1) TR200100636T2 (de)
WO (1) WO2000011010A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699846B2 (en) * 2000-03-17 2004-03-02 Corixa Corporation Mono- and disaccharides for the treatment of nitric oxide related disorders
US20030105032A1 (en) * 2000-05-19 2003-06-05 Persing David H. Phophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
US20030139356A1 (en) * 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
MXPA02011486A (es) 2000-05-19 2004-01-26 Corixa Corp Tratamiento profilactico y terapeutico de enfermedades infecciosas, autoinmunes y alergicas con compuestos a base de mono y disacarido.
WO2002012258A1 (en) * 2000-08-04 2002-02-14 Corixa Corporation New immunoeffector compounds
US7759803B2 (en) * 2001-07-25 2010-07-20 Rohm Co., Ltd. Semiconductor device and method of manufacturing the same
US7014991B2 (en) * 2001-11-16 2006-03-21 Infinite Vision, Llc Use of injectable dyes for staining an anterior lens capsule and vitreo-retinal interface
ES2336080T3 (es) * 2002-02-04 2010-04-08 Corixa Corporation Nuevos compuestos inmunoefectores.
US6911434B2 (en) 2002-02-04 2005-06-28 Corixa Corporation Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
US7288640B2 (en) * 2002-07-08 2007-10-30 Corixa Corporation Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor
MXPA05000407A (es) 2002-07-08 2005-04-19 Corixa Corp Procedimientos para la produccion de fosfato de aminoalquilglucosaminida e inmunoefectores de disacarido, e intermediarios para los mismos.
WO2005042766A2 (en) * 2003-10-31 2005-05-12 Molecular Targeting Technologies, Inc. Technetium-99m glucarate methods of use for monitoring tissues
WO2006107107A1 (ja) * 2005-04-01 2006-10-12 Fumitaka Ohsuzu リン脂質小胞体を含む心筋保護剤および虚血・再潅流時の心筋障害を予防する方法
US8697120B2 (en) 2006-05-01 2014-04-15 Johns Hopkins University Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury
WO2008134830A1 (en) * 2007-03-22 2008-11-13 Fundação Butantan Method to obtain monophosphoryl lipid a from bordetella pertussis as a by-product of the cellular pertussis vaccine production
BRPI0911195A2 (pt) * 2008-04-09 2017-06-20 The Univ Of North Caroline At Chapel Hill métodos de regulação de arranjo de citoesqueleto de actina e formação de gap intracelular

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5286718A (en) * 1991-12-31 1994-02-15 Ribi Immunochem Research, Inc. Method and composition for ameliorating tissue damage due to ischemia and reperfusion
AU1363699A (en) * 1997-10-23 1999-05-10 National Institute Of Health Methods for reducing ischemic injury of the heart via the sequential administ ration of monophosphoryl lipid a and adenosine receptor agents

Also Published As

Publication number Publication date
ATE263776T1 (de) 2004-04-15
US6013640A (en) 2000-01-11
NZ510260A (en) 2002-10-25
CA2340649A1 (en) 2000-03-02
NO20010854L (no) 2001-04-20
NO20010854D0 (no) 2001-02-20
HUP0103473A2 (hu) 2002-04-29
BR9913175A (pt) 2001-10-09
JP2002523420A (ja) 2002-07-30
EP1105401A1 (de) 2001-06-13
CZ2001637A3 (cs) 2001-10-17
DE69916289D1 (de) 2004-05-13
WO2000011010A1 (en) 2000-03-02
CN1324364A (zh) 2001-11-28
PL349422A1 (en) 2002-07-29
EP1105401B1 (de) 2004-04-07
US20020013291A1 (en) 2002-01-31
AU754186B2 (en) 2002-11-07
TR200100636T2 (tr) 2002-02-21
US6399590B2 (en) 2002-06-04
HUP0103473A3 (en) 2003-01-28
KR20010072806A (ko) 2001-07-31
IL141496A0 (en) 2002-03-10
AU5683299A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
ID28984A (id) Fosfoglikolipid dan metoda penggunannya
TR200101124T2 (tr) N-(2-aril-propiyonil)-sülfonamidler ve bunları içeren farmasötik preparasyonlar.
BR0014293A (pt) Uso de retigabina para o tratamento de dor neuropática
CA2261848A1 (en) Cell adhesion inhibitors
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
TR200000481T2 (tr) N-Alkonoilfenilalenin türevleri.
EA200200619A1 (ru) Непептидильные ингибиторы vla-4-зависимого связывания клеток, применяемые при лечении воспалительных, аутоимунных и респираторных заболеваний
NO891082D0 (no) Fremgangsmaate for fremstilling av peptidforbindelser.
BR8904263A (pt) Adjuvante apropriado para uso com agentes de protecao de culturas,composicoes herbicidas e processo para aumentar a eficacia de agentes de protecao de culturas
PT928788E (pt) Compostos farmaceuticamente activos
EA200500804A1 (ru) Топические противоинфекционные композиции
BR9909087A (pt) Formulações para proteção de conjugados peg-alfa interferon
ES2036179T3 (es) Procedimiento para preparar monohidrato de hidrocloruro de (s)-(-)-1-propil-2',6'-pipecoloxilidida.
FI94354C (fi) Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi
DE3463766D1 (en) Radioprotector agents with an aminothioalkyl structure, and process for their preparation
EP1043989A4 (de) Verwendung von mek1-inhibitoren als schutzmittel gegen ischemiebedingte schäden
WO1992017065A3 (en) Method of inhibiting fibrosis
CA2362833A1 (en) Phenylalaninol derivatives
NO174198C (no) Analogifremgangsmåte for fremst.av den terapeutisk aktive forbindelse 3-metoksy-4-(1-metyl-5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)indol-3-ylmetyl)-N-(2-metylfenyl-sulfonyl)benzamid, eller et farmasöytisk akseptabelt salt derav
EA199800658A1 (ru) Терапевтическое средство против астмы
NO970185D0 (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
DK0613375T3 (da) Farmaceutiske lysinholdige polypeptidpræparater og anvendelse deraf
WO2000002877A3 (en) New pharmaceutically active compounds
ZA993528B (en) A compound for use in treating glaucoma and ischemic retinopathy.
ATE197950T1 (de) Guanidylmethyl cyclohexancarbonsäure ester derivate